Immunohistochemical expression of metallothionein in human bladder cancer: Correlation with histopathological parameters and patient survival

Journal of Urology

Volumn 168, Issue 5, 2002, Pages 2227-2231

  Saga, Yuji ^a   Hashimoto, Hiroshi ^a   Yachiku, Sunao ^a   Tokumitsu, Masayuki ^a   Kaneko, Shigeo ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Bladder; Bladder neoplasms; Metallothionein; Prognostic factor; Tumor markers, biological

Indexed keywords

BIOCHEMICAL MARKER; FORMALDEHYDE; METALLOTHIONEIN; PARAFFIN;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; TISSUE DISTRIBUTION; TISSUE FIXATION;

EID: 0036837443     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64360-1     Document Type: Article

References (20)

1. Cherian, M. G. and Goyer, R. A.: Metallothioneins and their role in the metabolism and toxicity of metals. Life Sci, 23: 1, 1978
2. Karin, M.: Metallothioneins: proteins in search of function. Cell, 41: 9, 1985
3. Kagi, J. H. R. and Kojima, Y.: Chemistry and biochemistry of metallothionein. In: Metallothionein II. Basel: Birkhauser Verlag, p. 25, 1987
4. Kelly, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H. and Lazo, J. S.: Overexpression of metallothionein confers resistance to anticancer drugs. Science, 241: 1813, 1988
5. Wood, D. P., Jr., Klein, E., Fair, W. R. and Chaganti, R. S.: Metallothionein gene expression in bladder cancer exposed to cisplatin. Mod Pathol, 6: 33, 1993
6. Cherian, M. G., Huang, P. C., Klaassen, C. D., Liu, Y. P., Longfellow, D. G. and Waalkes, M. P.: National Cancer Institute Workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res, 53: 922, 1993
7. Haerslev, T., Jacobsen, G. K. and Zedeler, K.: The prognostic significance of immunohistochemically detectable metallothionein in primary breast carcinomas. APMIS, 103: 279, 1995
8. Ofner, D., Maier, H., Riedmann, B., Bammer, T., Rumer, A., Winde, G. et al: Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumour stage and patient survival. Virchows Arch, 425: 491, 1994
9. Moussa, M., Kloth, D., Peers, G., Cherian, M. G., Frei, J. V. and Chin, J. L.: Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen. Clin Invest Med, 20: 371, 1997
10. Chin, J. L., Banerjee, D., Kadhim S. A., Kontozoglou, T. E., Chauvin, P. J. and Cherian, M. G.: Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation. Cancer, 72: 3029, 1993
11. Siu, L. L., Banerjee, D., Khurana, R. J., Pan, X., Pflueger, R., Tannock, I. F. et al: The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma Clin Cancer Res, 4: 559, 1998
12. Kotoh, S., Naito, S., Sakamoto, N., Goto, K. and Kumazawa, J.: Metallothionein expression is correlated with cisplatin resistance in transitional cell carcinoma of the urinary tract. J Urol, 152: 1267, 1994
13. TNM Classification of Malignant Tumours, 4th ed. International Union Against Cancer. New York: Wiley-Liss Inc., 1987
14. Saika, T., Tsushima, T., Ochi, J., Akebi, N., Nasu, Y., Matsumura, Y. et al: Over-expression of metallothionein and drug-resistance in bladder cancer. Int J Urol, 1: 135, 1994
15. Somji, S., Sens, M. A., Lamm, D. L., Garrett, S. H. and Sens, D. A.: Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer. Cancer Detect Prev, 25: 62, 2001
16. Zhang, X. H., Jin, L. and Takenaka, I.: Localization of zinc and metallothionein in the rat bladder epithelium during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Urol Res, 24: 279, 1996
17. Tohyama, C., Suzuki, J. S., Hemelraad, J., Nishimura, N. and Nishimura, H.: Induction of metallothionein and its localization in the nucleus of rat hepatocytes after partial hepatectomy. Hepatology, 18: 1193, 1993
18. Woo, E. S., Monks, A., Watkins, S. C., Wang, A. S. and Lazo, J. S.: Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel. Cancer Chemother Pharmacol, 41: 61, 1997
19. Ogra, Y. and Suzuki, K. T.: Nuclear trafficking of metallothionein: possible mechanisms and current knowledge. Cell Mol Biol, 46: 357, 2000
20. Panemangalore, M., Banerjee, D., Onosaka, S. and Cherian, M. G.: Changes in the intracellular accumulation and distribution of metallothionein in rat liver and kidney during postnatal development. Dev Biol, 97: 95, 1983